Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for hepatocellular carcinoma.

Morris Sherman1

  • 1University of Toronto, Toronto, Canada.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
|September 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.

Gastroenterology·2026
Same author

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association.

JHEP reports : innovation in hepatology·2022
Same author

Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trial.

Canadian liver journal·2022
Same author

Reminiscences of a soon-to-be ex-hepatologist.

Canadian liver journal·2022
Same author

A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma.

Hepatology communications·2022
Same author

The viral hepatitis B care cascade: A population-based comparison of immigrant groups.

Hepatology (Baltimore, Md.)·2021
Same journal

Response to the Letter Regarding "Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis".

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Hepatitis B Virus Infection Status in Japanese Children Prior to Universal Vaccination: Sustained Effectiveness of Mother-to-Child Transmission Prevention and Residual Infection Burden.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative-Intent Local Treatment for Recurrent Hepatocellular Carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Comment on "The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy".

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Hepatic Steatosis Detected by Abdominal Ultrasonography Is Associated With Worse Prognosis in Underweight Patients.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
See all related articles

Regular screening for hepatocellular carcinoma (liver cancer) using ultrasound every six months is recommended for high-risk individuals, including those with cirrhosis or chronic hepatitis B, to reduce mortality.

Area of Science:

  • Hepatology
  • Oncology
  • Medical Screening

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Effective screening strategies are crucial for early detection and improved patient outcomes.
  • Methodological challenges exist in defining at-risk populations and optimal screening protocols.

Purpose of the Study:

  • To review and discuss methodological issues in hepatocellular carcinoma screening.
  • To identify the appropriate at-risk populations for screening.
  • To determine the optimal screening test and frequency for HCC.

Main Methods:

  • Review of existing literature on hepatocellular carcinoma screening methodologies.
  • Analysis of risk factors and patient selection criteria for screening.

Related Experiment Videos

  • Evaluation of ultrasonography as a primary screening tool.

    • Main Results:

    • Ultrasonography at six-month intervals is recommended for HCC screening.
    • Patients with cirrhosis and certain non-cirrhotic chronic hepatitis B patients are identified as high-risk groups.
    • Screening in these populations has demonstrated a reduction in HCC-specific mortality.

    Conclusions:

    • Screening for hepatocellular carcinoma using ultrasonography every six months is advised for at-risk individuals.
    • Early detection of small HCC tumors through screening can lead to curable outcomes.
    • While data for broader populations are limited, screening is recommended due to the potential for cure.